Micro Emerging Active

Saham SYNH naik 72% pada penjualan $8M, mengurangi kepemilikan oleh Kynam Capital

Skor
0,3
Kecepatan
▲ 0,0
Artikel
3
Sumber
1

Ringkasan

An article belongs to this narrative if it discusses changes in institutional holdings of Syndax Pharmaceuticals.

Artikel Terkait

Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges

Nasdaq · Mar 22, 2026
Mixed

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a …

Nasdaq · Mar 22, 2026
Mixed

Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems …

Nasdaq · Mar 21, 2026
Neutral

Sumber

Structure Therapeutics Slides 28% This Year as $6 Million Stake … Nasdaq
This $116 Million Buy Joins a 360% Stock Run and … Nasdaq
Biotech Stock Up 72% Sees $8 Million Sale, but Here's … Nasdaq

Lini Waktu

Terakhir Diperbarui Mar 21, 2026